Psychedelics public offering

A psychedelics-focused biopharmaceutical company Mind Medicine (MindMed) (NASDAQ:MNMD) announced Friday the pricing of an underwritten public offering of 9.29 million shares without par value, at a price of $7.00 per share. Through this round, the New York-headquartered company aims to raise $75...